Skip to main content
. Author manuscript; available in PMC: 2019 Mar 15.
Published in final edited form as: Cancer Res. 2018 Jan 12;78(6):1511–1521. doi: 10.1158/0008-5472.CAN-17-2457

Figure 3.

Figure 3

(A-B) The levels of Rbm38, p53, Pten proteins (A) and transcripts (B) were examined in T-lymphoblastic lymphomas from p53R270H/- and Rbm38−/−; p53R270H/- mice. (C-D) The levels of Rbm38, p53, Pten proteins (C) and transcripts (D) were examined in TLBLs from p53R172H/- and Rbm38−/−; p53R172H/- mice.